Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… CEPHRADINE Capsule; 250MG VELOSEF APOTHECON 061764 CEPHRADINE Capsule; 500MG VELOSEF APOTHECON 061859 CEPHRADINE Capsule; 250MG ANSPOR GLAXOSMITHKLINE 061859 CEPHRADINE Capsule; 500MG ANSPOR GLAXOSMITHKLINE 062683 CEPHRADINE Capsule; 250MG CEPHRADINE Teva 062683 CEPHRADINE Capsule; 500MG CEPHRADINE Teva 061763 CEPHRADINE For Suspension; 125MG/5ML VELOSEF '125' APOTHECON 061763 CEPHRADINE For Suspension; 250MG/5ML VELOSEF '250' APOTHECON 061866 CEPHRADINE For Suspension; 125MG/5ML ANSPOR GLAXOSMITHKLINE 061866 CEPHRADINE For Suspension; 250MG/5ML ANSPOR GLAXOSMITHKLINE 062693 CEPHRADINE For Suspension; 125MG/5ML CEPHRADINE Teva 062693 CEPHRADINE For Suspension; 250MG/5ML CEPHRADINE Teva ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com